Advancing NAMs for Fragrance Safety: Collaborative Research with RIFM and IFF. As innovators in in vitro skin sensitization testing, addressing key data gaps, we are pleased to share the publication […]
Click image to view the Newsletter in browser. Text-only version: SenzaGen’s Newsletter Dec 2024 As 2024 ends: We’re proud to share how our innovative GARD® method is addressing key challenges in […]
Click image to view the Newsletter in browser.
Improved Confidence of Quantitative Sensitizing Potency Assessment for Point of Departure Using GARD®skin Dose-Response Presented at SOT and Eurotox 2024 Download a copy in PDF Conclusion In conclusion, the […]
The applicability of GARD®skin for assessing skin sensitization potential of hydrophobic esters during product development Presented at Eurotox 2024 Download a copy in PDF Conclusion In conclusion, the inclusion […]
Case studies on the use of GARD®skin Medical Device for in vitro skin sensitization assessment Presented at SOT and Eurotox 2024 Download a copy in PDF Conclusion In conclusion, […]
New joint publication with L’Oréal. We are excited to announce the recent publication of a collaborative scientific paper by the expert teams at L’Oréal and SenzaGen, in Toxics MDPI. This […]
GARD®skin Dose-Response for skin sensitizing potency assessment: Performance on the Reference Chemical Potency List (RCPL) Presented at BTS 2024. Download a copy in PDF Conclusion This study suggests that […]
Click image to view the newsletter in browser.
New joint publication with International Flavors & Fragrances Inc (IFF) and Research Institute for Fragrance Materials (RIFM). SenzaGen scientists, alongside the scientific teams at International Flavors & Fragrances Inc and […]
